Contractor intelligence · computed from public award records
ONE PHARMA
- Awards won
- 8
- Known value
- USD 852K
- First award
- 22 Apr 2019
- Most recent
- 22 Jul 2019
Wins by funder
| Funder | Awards | Known value | Most recent |
|---|---|---|---|
| World Bank | 8 | USD 852K | 22 Jul 2019 |
Where the work is
EG · 8
Sources
The most recent award records behind the figures above. Every number on this page is computed from records like these — nothing is estimated or editorial.
- all technical offers are acceptable for The Sofosbuvir 400mg ,Daclatasvir 60 mg drugs · 22 Jul 2019 · USD 105K · World Bank
- alltechnical offers are acceptable The Sofosbuvir 400mg ,Daclatasvir 60 mgand Ribavirin drugs · 22 Jul 2019 · USD 107K · World Bank
- alltechnical offers are acceptable The Sofosbuvir 400mg ,Daclatasvir 60 mgand Ribavirin drugs · 22 Jul 2019 · USD 107K · World Bank
- alltechnical offers are acceptable The Sofosbuvir 400mg ,Daclatasvir 60 mgand Ribavirin drugs · 22 Jul 2019 · USD 107K · World Bank
- Purchase of hepatitis c drugs · 22 Jul 2019 · USD 107K · World Bank
- Procurement of hepatitis c drugs · 22 Jul 2019 · USD 110K · World Bank
- all technical offers are acceptable for The Sofosbuvir 400mg ,Daclatasvir 60 mg drugs · 23 Apr 2019 · USD 104K · World Bank
- all technical offers are acceptable for The Sofosbuvir 400mg ,Daclatasvir 60 mg drugs · 22 Apr 2019 · USD 105K · World Bank
Method
Computed from 8 award records ingested from official disclosure sources (World Bank, Inter-American Development Bank, and published contract-award notices). Values are shown in USD where the source published one; entity identity is resolved conservatively and reviewed. GLODA is not affiliated with any funder or contractor shown. Last computed 07 Oct 2026.